Current stock page

Stock Analysis

LivaNova PLC (LIVN) Stock Analysis

LivaNova PLC (LIVN) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.

LIVN Stock Analysis Summary

LivaNova PLC (LIVN) currently has an AIQ Score of 71/100, indicating a bullish setup. Momentum is the strongest factor at 83/100. Value is the weakest current factor at 60/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Nov 18, 2026 · Market-close data

LIVN at a Glance

Crawlable current metrics from the latest market-close stock snapshot.

MetricCurrent
Price$94.54
AIQ Score71/100
Overall ViewBullish
Technical Analysis ConsensusStrong Buy
Market Cap$5.03B
P/E Ratio (TTM)25.68
Forward P/E—
EPS (Q3 FY2026)$0.62
Revenue (Q3 FY2026)$393.1M
Dividend Yield (TTM)0.00%
Beta1.09
Volume1.32M
52-week range$52.37-$99.38
RSI 1465.47
50-Day SMA$80.32
200-Day SMA$74.18
Analyst Price Target$107.50
Next EarningsFeb 24, 2027
As of Nov 18, 2026 · Market close

LIVNLivaNova PLC

Healthcare / Medical - Devices

Leader

Strong Relative Position

BullishEdge 9/10
$94.54+$2.62 (+2.85%)

Latest quote

  • Momentum
    83
  • Value
    60
  • Quality
    64
  • Risk resilience
    71
  • Sentiment
    —
algovestiq.comScore data as of Nov 18, 2026

LIVN Stock Analysis Summary

LivaNova PLC (LIVN) currently has an AIQ Score of 71/100, indicating a bullish setup. Momentum is the strongest factor at 83/100. Value is the weakest current factor at 60/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Nov 18, 2026 · Market-close data
AIQ Composite Posture: Bullish

In a bullish regime, LIVN has AIQ Score of 71/100 with Momentum base of 83/100 and fading Value at 60/100. Wait for component alignment before adding exposure.

Signal Conflict Detected

Momentum (83/100) leads while Value (60/100) lags. This cross-factor spread creates entry timing uncertainty.

Healthcare · 2.85% stock move · LIVN classified in Medical - Devices.

Current Evidence

BullishLIVN is in a bullish AIQ regime; Momentum is the strongest visible factor at 83/100.
Core coverage reflects visible evidence only

AlgovestIQ Evidence Summary

Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.

Is LIVN Bullish or Bearish Right Now?

LIVN currently has a bullish overall setup. Momentum is the strongest factor at 83/100, while Value is weakest at 60/100. The current evidence suggests a constructive setup.

Bull Case
  • - Momentum is constructive at 83/100.
  • - Risk Resilience is supportive at 71/100.
  • - Price is +13.69% above its 50-day SMA.
  • - Analyst target implies +13.71% upside from the latest quote.
  • - Technical consensus has more buy votes than sell votes (35 vs 1).
Bear Case
  • - No strong bearish evidence is available in the current snapshot.

Current Consensus

LIVN's Technical Analysis Consensus is currently Strong Buy, with 35 buy, 10 neutral, and 1 sell votes. LIVN's 14-day RSI is 65.47, which places the stock in a constructive momentum range. LIVN's beta is 1.09, indicating market sensitivity broadly in line with the market.

Signal Confidence
High agreement

What Changed in LIVN?

The largest recent change in LIVN is Value moving down by 3.0 points over the available 7-day comparison window. Momentum remains the strongest visible factor.

AIQ Score
+0.0
Momentum
+1.0
Quality
+0.0
Risk
+1.0

What Would Change the LIVN Outlook?

The current bullish outlook could improve if AIQ reaches 65 (Bullish), momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 50 (Bearish), price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.

Bullish confirmation

AIQ 65+ (Bullish), RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.

Bearish deterioration

AIQ below 50 (Bearish), RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.

LIVN Decision Framework

Public evidence layers, setup checks, and risk context for LivaNova PLC.

LivaNova PLC (LIVN) Stock Analysis

LivaNova PLC has an AIQ Score of 71/100 in a Bullish regime. Momentum is strongest at 83/100. Beta is 1.09, close to market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.

Evidence LayerPublic Evidence
Regime ContextLIVN is in a Bullish AIQ regime with score 71/100.
Signal ConflictThe primary conflict is that momentum leads at 83/100 while value lags at 60/100.
Factor EvidenceMomentum 83/100 · Value 60/100 · Quality 64/100 · Risk 71/100
PersistenceCurrent snapshot evidence is shown; historical persistence remains in AIQ Pro.

Current Setup Checklist

Factor strengthPass

Momentum is the strongest factor at 83/100.

TimingPass

Momentum is 83/100 and RSI (14) is 65.5.

Regime fitPass

LIVN is in a Bullish regime at 71/100.

Risk controlPass

Risk factor is 71/100 with beta 1.09 and annual volatility 39.16%.

ConflictWait

Current conflict: momentum leads at 83/100 while value lags at 60/100.

AIQ Score
71/100
Price
$94.54
Beta
1.09
RSI (14)
65.5

LIVN Research Cluster

Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.

LIVN Fundamentals

LIVN valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.

Revenue
$393.1M
Net income
$34.3M
Free cash flow
$42.8M
View full LIVN fundamental analysis

LIVN Technical Analysis

LIVN technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.

Technical Analysis Consensus
Strong Buy
RSI 14
65.47
Price vs SMA-50
+13.69%
View full LIVN technical analysis

LIVN Stock Catalysts

Track LIVN earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.

Next earnings
Feb 24, 2027
Analyst target
$107.50
News items
5
View LIVN earnings and stock catalysts

LIVN Dividend Analysis

LIVN dividend yield, annual dividend, payout ratio, payment history, and income reliability context.

Dividend yield
0.00%
Annual dividend
—
Payout ratio
—
View LIVN dividend history and analysis

LIVN Financial Data

LIVN revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.

Quarter revenue
$393.1M
EPS
$0.62
Periods
8
View LIVN financials

LIVN Risk Analysis

LIVN volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.

Beta
1.09
Risk score
71/100
1Y volatility
39.16%
View LIVN risk analysis

LIVN Stock News

LIVN stock news, market tone, recent headlines, and catalyst context.

News items
5
Updated
Nov 18, 2026
Sentiment
—
Read LIVN stock news

LIVN vs Medical - Devices Peers

Current peer cohort: LIVN · NEOG · PACB · PEN · PHG. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.

PeerAIQValueMomentumRiskSharpe1Y VolatilityCompare
LIVN
Current stock
71/10060/10083/10071/1001.3839.16%Current
NEOG
Neogen Corporation
63/10049/10074/10057/1001.1957.93%LIVN vs NEOG
PACB
Pacific Biosciences of California, Inc.
48/10023/10084/10024/1000.6193.55%LIVN vs PACB
PEN
Penumbra, Inc.
66/10048/10056/10092/1000.6219.46%LIVN vs PEN
PHG
Koninklijke Philips N.V.
72/10080/10072/10073/1000.1829.69%LIVN vs PHG
Pairwise Compare links: NEOG · PACB · PEN · PHGLIVN vs NEOGLIVN vs PACBLIVN vs PENLIVN vs PHGCompare cohort

Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Nov 18, 2026.

About the AIQ Score

Methodology for the current stock evidence.

As of Nov 18, 2026 · Market close

The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.

View AIQ methodology

Factor Diagnostics

A compact bridge from the AIQ score to the evidence tabs.

Calculator
Calculate a LIVN stock return scenario

Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.

Calculate stock return

Also for LIVN: historical return with reinvested dividends, dollar-cost averaging (DCA) backtest and stock average calculator for several buys.

AIQ Component Profile

Compare the five component scores on one consistent 0–100 scale.

Catalyst preview

Review earnings timing, revisions, news pressure, and prior event reactions in one place.

Open catalysts
Quarterly evidence

8 recent quarterly periods are available for review.

Checked Nov 19, 2026

AIQ Pro

Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.

Fundamentals Verdict

Current snapshot fields are separate from reported-quarter statement tables.

Current TTM P/E
25.68
As of Nov 18, 2026
Revenue growth
9.87%
Gross margin
67.91%
Current debt / equity
0.25
Latest quarterly evidence

Latest period Sep 30, 2026.

Review fundamentals
Quarter revenue
$393.1M
Quarter net income
$34.3M
Quarter free cash flow
$42.8M

Market Confirmation

Technicals are summarized first, with the indicator library behind it.

Trend
Bullish
Momentum
Bullish
RSI 14
65.47
MACD
3.55

Risk Alignment

Higher resilience is stronger; exposure metrics stay separate.

Resilience
71/100
Beta
1.09
Annual volatility
39.16%
Max drawdown
-18.89%

LIVN Stock FAQ

What is LIVN stock price today?

LivaNova PLC's current stock price is $94.54. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.

Is LIVN bullish or bearish right now?

LIVN's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.

What is LIVN's market cap?

LIVN's market cap is $5.03B based on the latest completed market-close snapshot from Nov 18, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.

What is LIVN's current P/E ratio?

LIVN's current P/E ratio is 25.68 based on the latest completed market-close snapshot from Nov 18, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.

What is LIVN's RSI?

LIVN's 14-day RSI is 65.47 based on the latest completed market-close snapshot from Nov 18, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.

Is LIVN above its 50-day and 200-day moving averages?

LIVN is 13.69% from its 50-day SMA and 23.10% from its 200-day SMA based on the latest completed market-close snapshot from Nov 18, 2026. Moving-average position should be read with momentum and broader AIQ evidence.

When is LIVN's next earnings date?

LIVN's next earnings date is currently listed as Feb 24, 2027. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.

Does LIVN pay a dividend?

LIVN's dividend yield is 0.00% based on the latest completed market-close snapshot from Nov 18, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.